Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

Phase 2

Completed

Conditions: Multiple Myeloma
Acute Myelogenous Leukemia
Acute Lymphoblastic Leukemia
Myelodysplastic Syndrome

Interventions: Drug: Thiotepa
Radiation: total body irradiation
Drug: Busulfan
Drug: Melphalan
Drug: Cyclophosphamide
Drug: Fludarabine
Drug: Clofarabine
Procedure: (CliniMACS) T-cell depleted PBSC Transplant

First Posted Date: 2010-05-07

Last Posted Date: 2022-08-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 422

Registration Number: NCT01119066

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma

Phase 2

Completed

Conditions: Neuroblastoma

Interventions: Drug: Bevacizumab, Irinotecan and Temozolomide

First Posted Date: 2010-05-03

Last Posted Date: 2019-11-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 34

Registration Number: NCT01114555

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Clinical and Translational Study of STA-9090

Phase 2

Completed

Conditions: Colon Cancer
Rectal Cancer

Interventions: Drug: STA-9090

First Posted Date: 2010-04-28

Last Posted Date: 2015-11-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT01111838

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients

Completed

Conditions: Breast Cancer
Lymphoma

Interventions: Behavioral: questionnaires

First Posted Date: 2010-04-27

Last Posted Date: 2012-06-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 26

Registration Number: NCT01111201

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images

Terminated

Conditions: Lung Cancer

Interventions: Other: Breath-Hold PET/CT image set

First Posted Date: 2010-04-23

Last Posted Date: 2012-03-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 6

Registration Number: NCT01109953

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Cardiopulmonary Resuscitation (CPR) Video to Enhance Advance Care Planning in Advanced Upper Gastrointestinal Cancer Patients

Completed

Conditions: Pancreas and Hepatobiliary Cancer Patients

Interventions: Behavioral: (CPR) video and questionnaires
Behavioral: cardiopulmonary resuscitation (CPR) narrative script and questionnaires

First Posted Date: 2010-04-19

Last Posted Date: 2015-07-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 57

Registration Number: NCT01105806

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy

Phase 1

Active, not recruiting

Conditions: Bladder Cancer

Interventions: Other: external radiation therapy with gemcitabine

First Posted Date: 2010-04-15

Last Posted Date: 2024-06-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 19

Registration Number: NCT01104350

Locations: 🇺🇸
Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 2 locations

Does Maitake Mushroom Extract Enhance Hematopoiesis in Myelodysplastic Patients?

Phase 2

Completed

Conditions: Myelodysplastic Syndrome

Interventions: Drug: Maitake

First Posted Date: 2010-04-08

Last Posted Date: 2016-05-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 45

Registration Number: NCT01099917

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Digital Mammography for the Detection and Preoperative Staging of Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Procedure: Dual Energy Contrast Enhanced Digital Mammography (DE CEDM)

First Posted Date: 2010-03-15

Last Posted Date: 2015-09-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 82

Registration Number: NCT01086514

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Female Cancer Patients' Preference For Sexual Health Interventions

Completed

Conditions: Breast Cancer
Gynecologic Cancer

First Posted Date: 2010-03-10

Last Posted Date: 2017-07-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 229

Registration Number: NCT01084642

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy